Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
November 17th, 2018
15.9K views
Here we provide detailed protocols for the oral administration of antibiotics to mice, collection of fecal samples, DNA extraction and quantification of fecal bacteria by qPCR.
Overview
This protocol provides a reliable method to quantify changes in intestinal microbiota of mice following oral antibiotic administration. It aids research on microbiota interactions and pathologies associated with microbial dysbiosis.
Key Study Components
Area of Science
- Microbiology
- Neuroscience
- Pharmacology
Background
- Understanding the impact of antibiotics on gut microbiota is crucial for studying related diseases.
- Antibiotic treatment can lead to microbial dysbiosis, affecting overall health.
- Weight loss is a common side effect of antibiotic administration in mice.
- Protocols for effective administration and monitoring are essential for accurate results.
Purpose of Study
- To establish a method for administering antibiotics to mice without significant weight loss.
- To collect and analyze fecal samples for bacterial DNA quantification.
- To investigate the effects of antibiotics on gut microbiota composition.
Methods Used
- Preparation of antibiotic cocktails for oral gavage or drinking water.
- Collection of fecal samples and intestinal content post-euthanasia.
- DNA extraction from samples using commercial kits.
- Quantification of bacteria via qPCR analysis.
Main Results
- Mice administered antibiotics via oral gavage showed no significant weight loss.
- Antibiotics in drinking water resulted in initial weight loss but recovery was observed.
- Quantification of bacterial DNA revealed significant changes in microbiota composition.
- Standard curves were established for accurate measurement of 16S rDNA abundance.
Conclusions
- The protocol effectively minimizes weight loss during antibiotic treatment in mice.
- It provides a reliable method for studying the effects of antibiotics on gut microbiota.
- Findings contribute to understanding microbial dysbiosis and its health implications.
Frequently Asked Questions
What is the main advantage of this antibiotic treatment protocol?
It prevents significant weight loss in mice, which is typically associated with oral antibiotic administration.
How are fecal samples collected from mice?
Fecal pellets are collected directly from the anus using a restrainer.
What methods are used for DNA extraction?
Commercially available kits are used for extracting bacterial DNA from stool and intestinal samples.
How is bacterial quantification performed?
Quantification is done using qPCR analysis with established standard curves for accuracy.
What are the implications of studying gut microbiota?
Understanding gut microbiota interactions can provide insights into pathologies like inflammatory bowel disease.
How often should the antibiotic cocktail be replaced?
The antibiotic cocktail should be replaced with fresh stock twice a week during the experiment.
Executive Industry Relevance
This protocol enables reliable quantification of murine intestinal microbiota changes following oral antibiotic treatment, supporting preclinical studies of microbial dysbiosis linked to immunopathologies. By minimizing weight loss artifacts, it improves data interpretability for target validation in inflammation and immune-mediated disease models. The qPCR-based bacterial density assay provides quantitative, reproducible outputs essential for mechanistic de-risking and predictive confidence in early discovery workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of microbiota-immune crosstalk hypotheses in inflammatory bowel disease and arthritis models.
- Operational Value: Provides weight-stable antibiotic regimens that reduce confounding variables in target phenotype assessment.
- Predictive Value: Supports functional target validation by correlating microbial density shifts with immune cell functional readouts.
Screening & Assay Development
- Assay Readiness: Delivers standardized fecal sample preparation and DNA extraction compatible with high-throughput qPCR platforms.
- Quantitative Output: Generates 16S rDNA copy number measurements via standard curves, enabling lot-to-lot consistency in microbiome modulation studies.
- Scalability: Supports longitudinal sampling designs for dose-response and time-course screening campaigns.
Translational & Preclinical Research
- Disease Relevance: Models antibiotic-induced dysbiosis observed in human patients, enhancing translational validity of preclinical findings.
- Mechanistic De-risking: Links microbial community changes to immune cell function, reducing ambiguity in pathway-target relationships.
- Preclinical Continuity: Enables longitudinal tracking of microbiota recovery post-treatment, informing safety and resistance risk assessments.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing through lead optimization, providing microbiota modulation as a mechanistic variable in immunology and infectious disease programs.
- Discovery Biology: Supports hypothesis testing of microbiota-dependent phenotypes in disease models via controlled antibiotic perturbation.
- Screening: Enables assay-ready microbiome samples for evaluating compound effects on bacterial load and composition.
- Analytics: Delivers quantitative 16S rDNA abundance data that allows cross-condition comparison and effect size calculation.
- Translational Research: Connects murine microbiota changes to human-relevant dysbiosis patterns, supporting biomarker-aligned study designs.
- Enterprise Reuse: Establishes a reusable microbiota quantification capability applicable across multiple therapeutic areas and model systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing weight-loss confounders in microbiota-immune studies.
- Operational Value: Ensures reproducibility through standardized antibiotic cocktails and qPCR validation steps.
- Strategic Value: Improves go/no-go decisions by providing mechanistic links between microbial shifts and immune outcomes.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on microbiota-dependent disease relevance.
Implementation Considerations
- Requires expertise in murine handling, oral gavage technique, and anaerobic sample processing.
- Depends on qPCR instrumentation, standard curve generation, and DNA extraction kit compatibility.
- Necessitates cross-team standardization for sample collection timing, storage, and normalization procedures.
- Involves adaptation considerations when extending to different mouse strains, antibiotic combinations, or intestinal segments.
- Includes practical limitations such as the need for euthanasia to access intestinal tissue and potential variability in fecal pellet yield.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in microbiota studies?
Null hypothesis testing determines whether observed changes in bacterial density following antibiotic treatment are statistically significant, supporting confident target-phenotype associations in dysbiosis models.
How does independent variable isolation fit the discovery pipeline for antibiotic studies?
Isolating antibiotic treatment as the independent variable enables clear attribution of microbiota changes to the intervention, reducing noise in target validation experiments.
What quantitative dependent variable measurements enable microbiota assessment?
Quantitative 16S rDNA copy number measurements from qPCR enable precise tracking of bacterial load changes in fecal and intestinal samples over time.
Why do replication requirements matter for cross-functional collaboration in microbiome work?
Replication ensures that microbiota modulation results are consistent across operators and sites, supporting reliable data sharing between discovery and preclinical teams.
What statistical analysis capabilities are required before implementing qPCR microbiota quantification?
Linear regression analysis of standard curve C-T values versus copy number is required to accurately quantify 16S rDNA abundance in experimental samples.
Chapters in this video
0:04
Title
0:39
Administration of Antibiotics
2:29
Collection of Fecal Samples from Stool, Ileum Content and Ileum Wall
5:16
Quantification of Intestinal Microbiota by qPCR
6:33
Results: Quantification of Intestinal Microbiota by qPCR after Oral Antibiotic Treatment
7:51
Conclusion
